These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: L-nucleoside enantiomers as antivirals drugs: a mini-review.
    Author: Mathé C, Gosselin G.
    Journal: Antiviral Res; 2006 Sep; 71(2-3):276-81. PubMed ID: 16797735.
    Abstract:
    The discovery that some nucleoside analogues endowed with the unnatural L-configuration can possess biological activities has been a significant breakthrough in antiviral chemotherapy. In this regard, lamivudine (3TC) was the first L-nucleoside enantiomer approved against HIV and HBV, and several other L-nucleosides are currently under clinical development as antiviral agents.
    [Abstract] [Full Text] [Related] [New Search]